Component
Rat brain ascorbic acid content
Experimental model, exposure and limitations remain on each linked record.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
High-dose oral tartrazine lowered measured brain ascorbic acid in the rat experiment.
Experimental context and source evidence
- dose
- Tartrazine 700 mg/kg body weight for 2 weeks
- duration
- 2 treatment weeks; endpoint tissue analysis
- evidence_access
- Primary full-text methods/results and metadata.
- evidence_scope
- literature_reviewed; source-specific experimental curation
- experimental_model
- Male Wistar rats; six per group
- limitations
- Very high animal exposure. Results section reports lower ascorbic acid with no significant GSH or MDA change from tartrazine alone; broader abstract/discussion wording should not replace these results.
- nutrient_topic
- Tartrazine food-colorant chapter; nutrient, drug and peptide interactions retain their models and limits. · Tartrazine
- organism
- Male Wistar rats; six per group
- plain_language
- High-dose oral tartrazine lowered measured brain ascorbic acid in the rat experiment.
- primary_references
- High-Dose Aspirin Reverses Tartrazine-Induced Cell Growth Dysregulation Independent of p53 Signaling and Antioxidant Mechanisms in Rat Brain. (2019). https://pubmed.ncbi.nlm.nih.gov/31032366/ DOI: 10.1155/2019/9096404
- route
- Oral tartrazine
- tissue
- Brain tissue biochemical and histological endpoints
Tartrazine: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 358–367
Original AI-assisted curation of eighteen primary studies. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Male Wistar rats; six per group · source_derived_draft · unverified_draft
## tartrazine-brain-ascorbate High-dose oral tartrazine lowered measured brain ascorbic acid in the rat experiment. Model/species: Male Wistar rats; six per group Tissue: Brain tissue biochemical and histological endpoints Exposure: Tartrazine 700 mg/kg body weight for 2 weeks Route: Oral tartrazine Duration: 2 treatment weeks; endpoint tissue analysis Limits: Very high animal exposure. Results section reports lower ascorbic acid with no significant GSH or MDA change from tartrazine alone; broader abstract/discussion wording should not replace these results. Primary reference: High-Dose Aspirin Reverses Tartrazine-Induced Cell Growth Dysregulation Independent of p53 Signaling and Antioxidant Mechanisms in Rat Brain. (2019). https://pubmed.ncbi.nlm.nih.gov/31032366/ DOI: 10.1155/2019/9096404 Access: Primary full-text methods/results and metadata.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.